Measurement of Revascularization Effect Using NIRS in BTK Arteries
1 other identifier
observational
30
1 country
1
Brief Summary
Patient with occluded below the knee arteries and chronic limb ischemia Rutherford class V-VI are enrolled. During endovascular recanalisation procedure changes in tissue oxygen amount is recorded using near infrared spectroscopy (NIRS). Primary hypothesis - NIRS can be used to determine sufficient amount of blood reaching the ulcered ishemic area. Secondary hypothesis - NIRS can be useful in detecting early recoil after BTK recanalisation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2019
CompletedStudy Start
First participant enrolled
March 29, 2019
CompletedFirst Posted
Study publicly available on registry
April 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedApril 2, 2019
March 1, 2019
1.8 years
March 29, 2019
March 29, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Increase in oxygen amount sufficient for wound healing
12 months
Secondary Outcomes (1)
Detection of early recoil after BTK revascularization
1 hour
Interventions
Near infrared spectroscopy non invasively used to register changes in tissue oxygen amount during endovascular revascularization
Eligibility Criteria
All-comers meeting eligibility criteria in VMK hospital, Vascular surgery department.
You may qualify if:
- Critical limb ischemia Rutherford V-VI
- At least one artery below the knee is planned to revascularize
You may not qualify if:
- Blood oxygen saturation below 85% because of any comorbidities
- Life expectancy less than 12 months
- Unavoidable amputation above ankle
- Skin diseases preventing the use of NIRS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vilniaus Miesto Klinikinė hospital
Vilnius, LT-10207, Lithuania
Study Officials
- PRINCIPAL INVESTIGATOR
Tomas Baltrūnas
Vilnius University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Tomas Baltrūnas
Study Record Dates
First Submitted
March 29, 2019
First Posted
April 2, 2019
Study Start
March 29, 2019
Primary Completion
January 1, 2021
Study Completion
January 1, 2022
Last Updated
April 2, 2019
Record last verified: 2019-03